Clinical trial

Effect of 4 Weeks Treatment With Acipimox in Patients With Chronic Heart Failure

NCT00549614

Study summary

ClinicalTrials.gov

Effect of 4 Weeks Treatment With Acipimox in Patients With Chronic Heart Failure

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention acipimox Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-10-01

PhaseNA

Conditions

Heart Failureverified · MONDO: heart failure

Interventions

acipimoxDRUG

placeboDRUG

Sponsors & collaborators

University of Aarhuslead sponsor

Mapped research locations

Aarhus NDenmark1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00549614 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.